Browse by category

Analysis of the SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV...

Total weight loss did not increase for patients who took semaglutide before having BMS, suggesting that a surgery-first strategy could...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Semaglutide could also help people cut down on their alcohol intake, according to the findings from the ‘Human Laboratory Screening of...

Rani Therapeutics has revealed new pharmacokinetic (PK) and pharmacodynamic (PD) data from a preclinical study evaluating the oral...

The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to...

A study by Boston University School of Public Health (BUSPH) researchers has found that disparities in access to semaglutide, with rates...

Novo Nordisk has announced headline results from the STEP UP study, a phase 3b trial in the global STEP programme, which revealed the...

Biomea Fusion has announced ‘compelling’ results from in vivo studies of icovamenib in combination with semaglutide. Icovamenib is an...

Ascletis Pharma has revealed in a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg,...